Hygienicum, an institute of the GBA Group at the Graz site and a competence center for microbiology and molecular biology. The broad food and hygiene portfolio has now been expanded to include GMP testing. GMP-compliant infrastructure was created around an isolator for sterile testing and integrated into a QM system. Hygienicum thus joins the pharmaceutical sites of the GBA Group with microbiological testing facilities. The portfolio of the entire group ranges from clinical trial support and clinical testing laboratories to comprehensive chemical laboratory analysis.

Christian Klauke is the new Director of Business Development of LKF. After an apprenticeship in environmental technology in Dortmund and his Diplom study of biology at Kiel University, Christian gained experience as Head of Sales for more than ten years in the food sector. One of his biggest successes for his previous employer was the approval for the Chinese market.

ABF is proud to introduce Dinka Vukovic as its new Head of Business Development. Dinka brings insight and depth to this position, having served as ABF Head of Proposal and Competence Management for worldwide clinical trials for more than 2 years already.

Dinka is a trained pharmacist with 5 years of professional expertise in this field. She has also completed post graduate studies in Pharmaceutical Quality Management.

“I am thrilled to take over this new position and connect with our existing and future clients within Europe and globally”, said Dinka. "Additionally I am looking forward to all the clinical studies ABF can support with its services. As we say at GBA Group Pharma, your challenges require smart solutions.”

We are proud to announce, that LKF is since Feb. 2022 member of Life Science Nord. Life Science Nord is the regional industry network for medical technology, biotechnology and pharma for the states of Hamburg and Schleswig-Holstein. With some 500 companies, universities and research institutes and more than 260 active members, Life Science Nord is an important economic and innovation factor and a key element of the policy of both federal states.